Ozanimod Controls MS Disease Activity Regardless of Age
WEST PALM BEACH, Fla. — Clinical and radiologic measures of disease activity remained stable or improved for relapsing multiple sclerosis (RMS) patients in all age groups over 7 to 8 years of continuous treatment with ozanimod (Zeposia). “Regardless of age category, the adjusted annualized relapse rate was below 0.2 in the phase III parent trials […]
Long COVID May Be Difficult to Identify in MS
WEST PALM BEACH, Fla. – People with multiple sclerosis (MS) appeared to have a low risk of developing long COVID, but lingering complaints after SARS-CoV-2 infection were difficult to untangle from MS symptoms, registry analyses showed. In studies presented at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum, Robert Fox, MD, […]
Obesity Associated With Faster MS Disease Progression
WEST PALM BEACH, Fla. — Obesity in multiple sclerosis (MS) was tied to faster worsening of disability and an increased risk of physical, psychological, and cognitive decline, a prospective cohort study showed. Compared with normal weight, obesity was associated with a faster increase in scores on the Expanded Disability Status Scale (EDSS), which ranges from […]